Article Versions Notes

García Gómez C, Navarro E, Alcázar V, López-Guzmán A, Arrieta F, Anda E, Biagetti B, Guerrero-Pérez F, Villabona C, de Assín Valverde AR, et al. Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study. Journal of Clinical Medicine. 2023; 12(20):6556. https://doi.org/10.3390/jcm12206556

García Gómez, Carlos, Elena Navarro, Victoria Alcázar, Antonio López-Guzmán, Francisco Arrieta, Emma Anda, Betina Biagetti, Fernando Guerrero-Pérez, Carles Villabona, Andrés Ruiz de Assín Valverde, and et al. 2023. "Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study" Journal of Clinical Medicine 12, no. 20: 6556. https://doi.org/10.3390/jcm12206556

García Gómez, C., Navarro, E., Alcázar, V., López-Guzmán, A., Arrieta, F., Anda, E., Biagetti, B., Guerrero-Pérez, F., Villabona, C., de Assín Valverde, A. R., Lamas, C., Lecumberri, B., Rosado Sierra, J. A., Sastre, J., Díez, J. J., & Iglesias, P. (2023). Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study. Journal of Clinical Medicine, 12(20), 6556. https://doi.org/10.3390/jcm12206556